MedTrace Logo

Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use

NCT00968721 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2016-05-02

No results posted yet for this study

Summary

The primary purpose of this study is to pilot test an instrument that the investigators will develop to assess decision influences on inflammatory bowel disease patients' medication adherence decision-making.

This pilot study will use an exploratory, descriptive cross-sectional survey approach to pilot test the instrument and answer the research questions.

The main hypothesis is that patients at risk for intentionally modifying their prescribed medication regimen will differ on influences on decision-making, health status, and utilization of the IBD clinic services compared to those who are intentionally adherent and who continue adherence over time.

Conditions

Sponsors & Collaborators

  • Procter and Gamble

    collaborator INDUSTRY

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Lawrence S Gaines, Ph.D. · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00968721 on ClinicalTrials.gov